My Life – My Choice: Dying with Dignity

My Life – My Choice: Dying with Dignity

“I feel a great deal of sorrow that I can’t be fixed… I don’t want to die, but I can’t live like this, I can’t live in pain.”

In February 2015, Toronto resident, real estate broker and passionate dog-lover Kathy Wardle called long-time friend and ZoomerMedia producer John Thornton to ask if he would be interested in buying her Cabbagetown house because she was downsizing. Little did John know the real reason behind Kathy’s decision to sell.

Despite numerous surgeries and countless medications, including the maximum allowable daily dose of morphine, Kathy’s years of chronic pain had reduced her life to, in her words, “less than zero”. Uncertain about the timing of the Canadian government’s legalization of physician assisted death, Kathy began the lengthy and thorough process required to get the “green light” to legally end her life overseas in Switzerland.

My Life – My Choice: Dying with Dignity is the result of John and Kathy’s unexpected and emotional journey to document her final weeks and the aftermath of her brave and lucid decision through intimate conversations with family and friends, interviews with physicians and chronic pain experts.

Kathy’s preference would have been to die a graceful death at home in Toronto surrounded by loved ones. Her hope was that My Life – My Choice: Dying with Dignity would serve to create awareness about chronic pain and stimulate greater conversation around end of life care and end of life choice.


In the News

The topic of dying with dignity in Canada has been in the headlines a lot lately, thus providing Canadians with further information, insight and opinion on the matter.

Toronto Life
“I helped eight people end their lives. By the time you read this, I would’ve ended mine.”

[Read Full Article]

The Globe and Mail
“ALS sufferer first Canadian to receive judge’s approval for assisted death.”

[Read Full Article]

Metro
“Toronto Man wants to be Ontario’s first case of doctor-assisted suicide.”

[Read Full Article]

CBC.ca
“Archbishop of Toronto speaks out against assisted dying.”

[Read Full Article]

 DyingWithDignity.ca
“Dr. David Amies: With assisted dying report in hand, Ottawa has building blocks for new legislation.”

[Read Full Article]


thezoomersmOn Monday, March 14 at 9pm ET/6pm PT, tune in for a special edition of theZoomer. Here, the panel will discuss the subject of assisted dying. My Life – My Choice: Dying with Dignity, will air directly afterward at 10pm ET/ 7pm PT.

 
Facebook F LogoDo you have an opinion on My Life – My Choice: Dying with Dignity and/or the topic of assisted suicide? If so, please click here to join the conversation on VisionTV’s official Facebook page.

DEA Agent Scott played fast and loose with the rules ?

rottenappleStar DEA agent finds himself at center of sprawling probe as drug task force comes under scrunity

http://www.theneworleansadvocate.com/news/15135428-125/star-dea-agent-finds-himself-at-center-of-sprawling-probe-as-drug-task-force-comes-under-scrunity

The U.S. Drug Enforcement Administration for years considered Chad Scott a golden boy among its special agents, a prolific narcotics officer who earned countless plaudits for the DEA’s New Orleans field division. Others knew him as a champion waterskier, a tan, blond boss of the single ski.

 

His legend extended to the world of drug traffickers, where Scott styled himself the “white devil,” a ruthless cop who strong-armed informants and boasted to suspects that he was “the baddest (mother)” along the Interstate 12 corridor.

 

One dealer loathed Scott so much that he hatched a plan to have the agent executed for $15,000.

Scarface, a popular Houston rapper, name-checked Scott in a controversial album that taunted the DEA — music the brash agent liked to play at high volume following drug arrests.

Some colleagues, though, thought Scott — now at the center of a widening investigation — played fast and loose with the rules, even comparing him to the crooked detective played by Denzel Washington in the movie “Training Day.”

 Attorneys for some of his targets share that view.

“I’ve always felt that he was sort of off the books, that he was a guy who would go to extremes that I felt violated a sense of equal justice,” said Arthur “Buddy” Lemann III, a veteran defense attorney who recently accused Scott of committing “outrageous misconduct” in a federal drug case. “There’s got to be some sense that you can only go so far, and Chad Scott has always been right on the periphery of that — if not overstepping it.”

But some of Scott’s law enforcement brethren say he’s one of the best agents they’ve ever worked with.

 

“I knew Chad Scott, and still know him, to be a fine, upstanding public servant whose dedication has been an overwhelming asset to this community,” said defense lawyer Matt Coman, a former federal prosecutor who worked closely with Scott for years. “His work has gone a long way toward continuing to eradicate the scourge of illegal drugs in this community. He’s a fantastic person, a fantastic agent — a credit to that agency.”

Whether Scott is a rogue officer or an aggressive but outstanding agent, his storied career has been turned upside down in recent weeks, as Scott has found himself in the middle of a sprawling investigation into misconduct on a multiple-agency drug task force that he led.

The criminal inquiry, taken over recently by the FBI, has focused on several sheriff’s deputies who served on the task force and are suspected of peddling drugs and stealing cash seized in at least two suburban parishes.

 

But Scott is also in the crosshairs, according to multiple law enforcement sources.

The DEA has declined to comment on Scott’s status, refusing even to say whether he still works for the agency. But three law enforcement sources confirmed last week that Scott has been stripped of his gun and badge and suspended from duty.

The suspension marks at least the fourth time Scott has been disciplined at the DEA, according to law enforcement officials who spoke on the condition of anonymity because they were not authorized to speak publicly.

 

It’s exceedingly rare for federal officers to face criminal charges, and it’s not clear yet whether the government intends to charge Scott — or what it might charge him with. It is also unclear whether any DEA agents other than Scott are being investigated by the FBI.

Scott did not respond to messages seeking comment last week.

Along with the criminal probe, the DEA also has launched a sweeping internal investigation into the task force led by Scott that involves both the agency’s Office of Professional Responsibility and the Office of the Inspector General.

 

Internal investigators have been working intensively at the DEA’s New Orleans Field Division, which saw a shakeup last month when Keith Brown, who headed the office’s four-state operation, was reassigned amid the spiraling scandal to DEA headquarters in Washington, D.C.

Changes in policies

The scandal could have far-reaching effects on federal and state drug cases, past and present, around the New Orleans area. It already has prompted significant changes in the DEA’s local policies for handling evidence and, according to an agency memo, even security protocols at the agency’s Metairie office on Causeway Boulevard.

 

Two members of the DEA task force — former Tangipahoa Parish Sheriff’s Office Deputies Johnny Domingue and Karl E. Newman — have been booked on a long list of conspiracy and drug distribution charges.

Domingue, who has given extensive interviews to law enforcement since his Jan. 26 arrest, pleaded guilty on Friday to four counts, admitting he conspired with Newman to steal an array of narcotics and cash from suspects and DEA evidence lockers.

Multiple sources said more arrests are in the offing, and court documents filed in connection with Domingue’s guilty plea describe the role of an unnamed law enforcement official in the alleged scheme.

 

The fallout from the scandal almost certainly will include legal challenges brought by defendants in cases involving Domingue, Newman and, if he is charged, Scott, who has worked with the DEA for 17 years and been involved in some of the agency’s most notable busts.

The case also has opened an unusual window into the sometimes blurry line that separates narcotics officers from the underworld of drug dealers and snitches whom they rely on for tips.

Some of Scott’s colleagues began to question his allegiances more than a decade ago, according to law enforcement officials, and they alleged on multiple occasions that Scott flagrantly disregarded DEA policies. Those claims prompted internal inquiries that typically absolved Scott of the most serious charges, such as allowing his informants — the agency refers to them as “confidential sources” — to continue dealing drugs.

 

Scott once was suspended for allowing an informant, Shawn N. LaBee, to use his own money as a so-called “flashroll” — cash shown to a dealer to establish bona fides during a drug deal. That practice violates DEA policy.

Records reviewed by The New Orleans Advocate show the DEA and Louisiana State Police received a citizen complaint as early as 2004 that Scott had been “supplying narcotics” to an individual. The complainant, a Washington Parish woman, claimed to have witnessed Scott taking drugs from a residence after an arrest.

“He seizes a lot of dope and a lot of cash, and he makes his managers look good,” said one law enforcement official, who spoke on condition of anonymity. “Case-makers are protected.”

 

The authorities appear to be reinvestigating several of Scott’s cases — past and pending — as well as examining allegations that he has planted drugs and improperly recruited informants from a halfway house. One case being scrutinized involves the disappearance of tens of thousands of dollars seized in a recent drug interdiction, said another law enforcement official familiar with the probe.

Drawn to narcotics work

Scott began his law enforcement career in Tangipahoa Parish, where he was hired as a sheriff’s deputy in the early 1990s. Soon, he was assigned to narcotics, making high-profile busts and earning a reputation as an agent who could bring home the big case and, crucially, the big seizure.

 

“I got to know Chad Scott when I was an assistant district attorney, probably in 1994, my first year,” said Daniel Edwards, the current sheriff of Tangipahoa Parish and brother of Gov. John Bel Edwards. Daniel Edwards, who prosecuted a large number of drug cases, remembered Scott as a standout cop.

“If my memory serves, he made more cases than any other agent at (the Sheriff’s Office),” Daniel Edwards said. “Certainly, the bigger cases, the bigger seizures tended to be his.”

The exact dates of Scott’s tenure with the Tangipahoa Parish Sheriff’s Office are unclear; Daniel Edwards’ attorneys said he inherited almost no personnel files from his predecessor, Ed Layrisson, when he took office in 2004.

 

Scott had left for the DEA years before that, but the Sheriff’s Office still periodically received complaints about him, according to a former office employee. “Daniel Edwards’ standard response was that he works for the federal government,” the former employee said.

Scott testified last year that he began working on the DEA task force when he was still a sheriff’s deputy. He said he left the Sheriff’s Office after nine years to join the federal agency.

For a time, the task force was led by DEA Special Agent Dave “Chicken” Gorman, who considered Scott a model agent.

 

“I wish I’d had four or five just like him,” Gorman, who is now retired from the agency, said in an interview. Scott wrote good case reports, brought strong cases and rarely had to be questioned by superiors or prosecutors, Gorman said.

By December 1998, court records show, Scott was working in Houston, where he was assigned soon after he was hired by the DEA. There, he quickly found himself in the middle of a politically charged case the DEA and Houston police were pursuing against Houston rap mogul James Prince, owner of a major record label called Rap-A-Lot. Scott and another DEA agent, Johnny Schumacher, were assigned to the case.

During the investigation, Prince and others made allegations of civil rights violations and racial profiling in the DEA’s handling of the case; their complaints found an audience with U.S. Rep. Maxine Waters, D-Calif. Waters sent a letter to then-Attorney General Janet Reno, who halted the probe in 1999.

 

Prince’s complaints also found their way into the label’s music, especially in two songs by Scarface, the rapper, who took shots at the DEA and police, naming Schumacher in one song and including a reference to “Chad” in another. Though the reference was oblique, DEA officials made clear in congressional hearings that they believed the song was calling out Scott.

Back to Tangipahoa

The DEA investigated Schumacher and Scott for several alleged transgressions. Schumacher ultimately was cleared, but Scott received a letter of reprimand because a gold necklace confiscated during the DEA’s probe of Prince was found in his desk, according to congressional testimony.

 

Sometime after that, Scott, still a DEA agent, returned to his old stomping grounds and began working cases in Tangipahoa Parish. He reconnected with Daniel Edwards, who was still in the District Attorney’s Office. When Edwards became sheriff in 2004, he began working more closely with Scott.

“The working relationship probably got closer,” Edwards recalled. Edwards frequently assigned one or two of his deputies to the DEA task force, a common arrangement in areas around the country. And the group kept making cases.

“I have never known him not to be an effective agent,” Edwards said of Scott. During that time, the sheriff added, he never heard allegations of impropriety.

 

Edwards said he and Scott were friends but only through work.

“I considered Chad a personal friend, yes. But I have never been to his house. I have never bought him Christmas gifts. I don’t know when his birthday is,” Edwards said. “When you work with someone enough, you can become close to him and consider him a friend.”

A fresh complaint against Scott landed in U.S. Attorney Kenneth Polite’s New Orleans office last fall. It came from Laurie White, an Orleans Parish Criminal District Court judge, and was accompanied by an email Scott sent her on Sept. 25 from his government account.

 

The special agent, greeting the judge as “Laurie,” chided her for her acquittal last summer of an accused cocaine and heroin dealer, a case Scott had put together. In the email, Scott contrasted White’s verdict in that proceeding with her reaction to an unrelated break-in that month at her French Quarter home — an incident in which her husband was attacked in the courtyard.

White had told WVUE-TV that New Orleans police — though armed with video — minimized the incident by booking the suspect, Joshua Stemle, on municipal misdemeanor charges only.

Scott, in his email, drew a comparison to the case of Theltus Williams, a man White acquitted in a bench trial in June that featured video evidence of drug purchases by a confidential informant. He told the judge he found her criticism of the New Orleans Police Department to be ironic.

 

White declined to provide Scott’s email to The Advocate. But she said she took its sardonic condolences over her husband’s assault as a form of intimidation. In an interview, she called the email “inappropriate” and acknowledged filing the complaint against Scott.

‘Reasonable doubts’

White’s acquittal of Williams drew media criticism and an angry rebuke from District Attorney Leon Cannizzaro.

 

In her written ruling, the judge didn’t spell out her reasons for the verdict in the face of evidence that included marked DEA drug-buy cash found in a search of Williams’ home and rare testimony from a confidential informant.

“Every molecule of my being wanted to ignore the reasonable doubt that I had at the close of the trial,” she wrote in her one-page ruling. White also professed a “great respect for the lawyers in this case, as well as DEA Agent Chad Scott and the other agents in this matter.”

But White said in the interview that she didn’t believe Scott’s testimony when he insisted nothing had been offered to the informant, Luke Matthews, for helping nab Williams or for testifying at his trial.

 

Matthews frequently brought cases to Scott, and he testified that he was hustling for a payoff — de facto immunity from possible drug charges related to a 2009 bust in Tangipahoa Parish that sent him back to prison, but only on a probation violation. That break was thanks to Scott, Matthews testified.

Prosecutors had assured Williams’ attorneys before the trial that they hadn’t offered the informant anything. And Scott testified that he didn’t seek new drug charges against Matthews only because a confidential informant who helped bust Matthews had himself picked up a new drug charge.

“I had reasonable doubts,” White said, citing what she described as conflicting accounts between the informant and the agent.

 

“A witness was believed over him,” she said of Scott.

White also said the video was not enough to convict Williams based on three taped drug buys spanning more than a year. “The video was impossible to understand, and there were no transcripts of the minute-by-minute transactions. In the video, you do not see the drug transactions occurring,” White said.

She said she declined to spell out her suspicions of Scott in her written ruling, as a precaution.

 

“I didn’t want to affect the future of an agent for maybe not presenting a good case,” she said. “I don’t want to talk about who I believe or disbelieve because it could affect cases in the future.”

Staff writer Gordon Russell contributed to this report. Follow Jim Mustian on Twitter, @JimMustian; Faimon A. Roberts III, @faimon; and John Simerman, @johnsimerman.

Drug dealers selling heroin in tandem with Narcan

Mayor: Drug dealers selling heroin in tandem with Narcan

http://www.wmur.com/news/mayor-drug-dealers-selling-heroin-in-tandem-with-narcan/38475186

MANCHESTER, N.H. —It may seem contradictory, but Mayor Ted Gatsas believes drug dealers are selling heroin, fentanyl and the drug that reverses that high.

A director from a treatment facility in Manchester said the availability of the life-saving drug Narcan does not encourage addiction.

“It is now a selling tool,” Gatsas said.

As he was walking out of his Manchester office Thursday, Gatsas said a “tough” young man approached him.

“And he said to me, ‘Mayor, there’s going to be a lot less deaths in Manchester in the next few months.'”

Prompted, Gatsas asked how that was going to happen.

“And he said, ‘That’s because the dealers have started to buy Narcan and carry it with them,'” Gatsas said.

“‘And they’ll give you your heroin or whatever they’re selling you, and they’ll tell you that, if you have a problem, you’ll have Narcan to bring you back.'”

Gatsas thinks this practice could be dangerous, because many overdoses require more than one dose of naloxone, or Narcan, to reverse the effects of drugs.

But Stephanie Bergeron, of Serenity Place, doesn’t think dealers selling Narcan is an issue.

“We haven’t heard anything about Narcan being sold in tandem to heroin,” Bergeron said. “That is a new statement on our end as a treatment facility. You can get Narcan over the counter at places like CVS. So i’m not sure if that’s actually happening.”

Even though Narcan is available over the counter, Bergeron said she hasn’t heard of her clients buying Narcan before they used heroin as a fail-safe.

“It doesn’t really make sense, because if you’re using, and you’re afraid that you might overdose, and you bought Narcan, you would need someone to administer it to you,” Bergeron said.

Narcan is a small weapon to battle the opioid epidemic, Bergeron said.

“Harm reduction is kind of meeting a person where they’re at. So if keeping them alive with Narcan after there’s an overdose, that’s certainly harm reduction, because they’re alive,” Bergeron said. “That person may not be ready for treatment.”

American Medical Response said 14 people died last month in Manchester alone of suspected opioid overdoses. It is a new record.

Politicians are not REAL DOCTORS… they just PLAY ONE in the legislature ?

States Move to Control How Painkillers Are Prescribed

http://www.nytimes.com/2016/03/12/business/states-move-to-control-how-painkillers-are-prescribed.html?smtyp=cur

A growing number of states, alarmed by the rising death toll from prescription painkillers and frustrated by a lack of federal action, are moving to limit how these drugs are prescribed.
From Our Advertisers

On Thursday, Massachusetts lawmakers passed a bill expected to be signed next week that would sharply restrict the number of pain pills a doctor can prescribe after surgery or an injury to a seven-day supply. Officials in Vermont and Maine are considering similar actions, and governors across the country are set to meet this summer to develop a broad approach that could reduce the use of painkillers like OxyContin, Percocet and Vicodin.

The states’ push points to a looming change affecting how doctors use narcotic painkillers, or opioids, which are the most widely prescribed class of medications in the United States. The move comes against the backdrop of a public health crisis involving heroin-related overdoses.

The governor of Vermont, Peter Shumlin, said in an interview that states were taking action because drug industry lobbyists had the ability to block federal initiatives.

“The states are going to lead on this one because Big Pharma has too much power,” said Mr. Shumlin, a Democrat.

In recent years, some states have enacted tough new rules to reduce prescriptions for the drugs. But the pace of activity in states has grown so intense that experts are having difficulty keeping track. Currently, there are about 375 proposals in state legislatures that would regulate pain clinics and several aspects of prescribing painkillers, according to the American Academy of Pain Management, an organization for medical professionals that receives drug industry funding.

Even some physician groups that have long opposed legislative interference in how doctors practice have softened their stance. For example, the Massachusetts Medical Society, while opposing a proposal of a three-day limit on initial opioid prescriptions for acute pain, supported the seven-day cap adopted on Thursday by state lawmakers. Some doctors and dentists give patients as many as 60 or 90 painkillers containing narcotics such as oxycodone or hydrocodone, giving rise to potential misuse of the drugs or opening a door to addiction.

“Usually we are opposed to carving anything in stone that has to do with medical practice,” said Dr. Dennis Dimitri, president of the Massachusetts Medical Society. “But we are willing to go forward with this limitation because we recognize this is a unique public health crisis.”

In 2014, the death toll from overdoses involving prescription painkillers or heroin reached 28,647, a 14 percent increase from the previous year, according to federal data. Many recent heroin deaths involve the use of illicitly produced fentanyl, a prescription opioid often mixed with heroin.

It is unclear what effect the laws about prescription painkillers are having on death rates, which in some ways are the ultimate measure for any public policy aimed at reducing substance abuse. Some experts argue that measures to reduce prescribing painkillers may be having the unintended consequence of driving people to try heroin and other illicit drugs. Others dispute that, pointing out that the shift toward heroin use happened before the recent policy focus on opioids took hold.

Advertisement
Continue reading the main story

The use of opioids began to skyrocket in the 1990s in the face of claims by pharmaceutical companies and medical experts that opioids could be used to treat conditions like back pain and arthritis without fear of addicting patients. But as their misuse and abuse became rampant, public health officials, doctors, regulators and pain-treatment advocates remained deadlocked for years over how to address the public health crisis, arguing over whether tighter prescribing rules would penalize patients who needed the medications.

Some patient and medical groups maintain that little scientific data exists to warrant major new restrictions. But such arguments appear to be losing sway.

Along with the threat of addiction, there is also growing evidence that when given to patients in high doses, opioids pose a greater risk of overdoses as well as problems such as sleep apnea, sharply reduced hormone production and increased sensitivity to pain.

“We have a much better sense of the risks,” said Dr. Bruce Psaty, a researcher at the University of Washington in Seattle, who studies drug safety. “The culture has begun to change.”

Sales of opioids reached an estimated $1.98 billion in 2014, according to IMS Health, a research firm that collects prescribing data. There is little question that the drugs help tens of thousands of patients function better, including those suffering from chronic or long-lasting pain.

The moves now underway in Massachusetts and other states are not the first attempts to control how drugs are prescribed. Every state, with the exception of Missouri, now has a so-called prescription monitoring program to try to stop people from getting prescriptions from multiple doctors.

But while many of those programs have been voluntary, big impacts have occurred in places that require doctors to check the databases before writing a prescription.
These rules paint in such broad strokes that those with legitimate need who use opioid analgesic medications appropriately are lumped with…
These comments are from patients are compelling. I hope the NYT and lawmakers notice. However my hunch is that people who suffer or have…
Elizabeth Schaper 54 minutes ago

Having had 5 major spine surgeries during the past 11 years, at age 63 now, and about to undergo my 6th, I have been taking pain medication…

For example, after Kentucky passed a series of measures in 2012 including one requiring doctors to make such checks, opioid prescribing in the state fell 8.6 percent in one year, according to a 2015 report by researchers at the University of Kentucky in Lexington.

Some states have also started to look at a program used since 2012 by an insurer, Blue Cross and Blue Shield of Massachusetts, as a possible model.

Under the program, doctors cannot initially issue more than a 15-day supply of painkillers and doctors are restricted from prescribing more than 30 days’ worth of the drugs over a two-month period. In addition, they must seek prior approval from the insurer before prescribing long-acting narcotics such as OxyContin, except for cancer patients or those receiving palliative care.

Over the last three years, Blue Cross and Blue Shield of Massachusetts has found an 18 percent decline in the volume of opioid doses prescribed and a 50 percent drop in prescriptions for OxyContin and other long-acting opioids. Tony Dodek, an associate chief medical officer at the insurer, added that if it was developing the plan today, the insurer would most likely place a tighter limit on initial prescriptions.

Mr. Shumlin, the Vermont governor, said he expected that members of the National Governors Association would discuss opioid prescribing strategies when they meet in July.

“If we could adopt policies regionally or nationally, we could make some real progress,” he said.

As state initiatives gather momentum, there is even movement at the federal level.

The Centers for Disease Control and Prevention is expected to issue soon guidelines urging doctors to use opioids sparingly and treat pain first with nondrug approaches.

The effort has run into opposition. Some patient and doctors groups, including those funded by the drug industry, have charged that the guidelines were developed behind closed doors without their input and that they should not be published until more scientific evidence to justify them is developed.

In Washington, the Senate passed a bill on Thursday that would authorize funds for states to underwrite addiction treatment services and prescription monitoring databases, though it did not provide immediate money for the measures.

ABC 20/20 Breaking point Heroin in America

IMG_0112

If you wish to watch the whole show here is the link.

http://abc.go.com/shows/2020/listing/2016-03/11-031116-breaking-point-heroin-in-america

After watching this “special”.. it is clear why it took them over ONE YEAR to get it together… I just wonder how many families they had to follow to find the “worse case story” they could broadcast… I guess that is what sensational journalism is all about..

They had THIRTY NATIONAL ADVERTISERS on this program:

HomeAdvisor.com              Gain Detergent                   Geico                     Zillow.com              800AskGary.com                Progressive Insurance

Kraft Foods                           Verizon Cellular                 Banquet Foods    Vision Works          Dannon/Activia                  ATT Cellular

Quicken Loans                      Huggies                               Dell Computers   Honda                       EHarmony.com                  Red Lobster

Lexus                                      Truecar.com                       Kohls                     Werthers Candy      Allegra                                  H&R Block

AARP                                     Yoplait Yogurt                     Ford                       Downey Softner        Farmer’s Ins                      marie callender’s

Builders Supply

They start off talking about the 129 that die everyday of drug overdoses… of course this story is about Heroin… no sense of mentioning that  57 deaths are from OTC medications… after all the story is based on Heroin abuse… which accounts for abt 17% of all overdose medication deaths.. no sense in confusing the people watching the show with FACTS …

They move on the state that these drug over doses are greater than car accidents – abt 40,000/yr – and guns abt 11,000 homicides.

Again they state that 4 out of 5 Heroin users started out with prescription opiates… they , of course, never clarified if they started with a legal Rx for opiates, got them from friends/family, on the street or robbed a pharmacy… again no sense in confusing the audience with FACTS.

The first family (Aaron & Catlin)… both are Heroin abusers… but the only history that is provided is that Aaron has OD’ed TWICE before and Catlin is currently in rehab.. Also notice that Aaron is a SMOKER.. claimed to be the most addicting drug out there and causes abt 450,000 deaths/yr, but this story is Heroin addiction and 8,000 deaths.  Also, at least Aaron’s MIL was a smoker as well…

They mention that “China White”  ( Heroin mixed with Fentanyl) and claim that Fentanyl is 50 times more potent than Morphine… which is true if Fentanyl citrate was being used – like the commercial product like Duragesic – but the Fentanyl being mixed is from China is AcetylFentanyl… which is only about 7% potency of Fentanyl citrate .. again don’t confuse the audience with FACTS.

Of course, after Aaron had OD’ed the first time, they could have put him on Vivitrol (long acting Naloxone)… shot every 28 days.. and there would be no more “highs” or OD’s for Aaron, but instead .. they allow him to OD a second time and then send him to The Phoenix House were his recovery is done cold turkey and using “talk therapy” … where he fails… OD’s and dies after 8 days.

Then we meet Matt and Savanna .. Matt is working for $10/hr and Savanna is on Subutex at a cost of $17/day…abt 30% of Matt’s weekly pay. Just like Aaron & Catlin… Matt and Savanna are both Heroin addicts..IMG_0107

Matt tried to show a judge that he is clean, a family man, steady job holder… this seemingly “heartless” judge.. decides that he is not rehabilitated enough.. imposing a $5000 bond and breaking up the family and putting the “bread winner” in jail.. So now his wife and baby daughter has to find how to financially survive. Savanna apparently spirals out of control.. ends up in jail… the baby girl ends up living with her Grandmother.

 

 

IMG_0110  New Hampshire spends TWENTY TIMES more money on law enforcement than treatment. If the state had paid for Savanna’s Subutex ($17/day) … and the judge had been a little more open minded… Savanna and Matt could still have been a happy family.. Matt could have been a productive member of society. Instead the state is now having to bear the cost of incarcerating both of them and probably bearing some cost for raising their daughter via Medicaid.

 

 

 

IMG_0111The DEA agent says that this a medical issue, a public health issue and law enforcement issue. It would not be hard to imagine if the two couples that were the focus of this story that if “the system” had been more focused on their medical needs… Aaron might be alive and Matt and Savanna , Aaron and Catlin may have been a intact family. Being productive members of society… instead of being a liability on the system.

 

Also notice that when they went to the local bureaucrats to get the approval to open a residential home for single mothers in recover… TWO of the FIVE BUREAUCRATS voted NO!.. and the chairman of the counsel did not sound happy that the vote passed to approve the home.

Is it just me, or did that vote and the tone of the chairman’s statement… spoke volume about the attitude and mindset of that community and perhaps the whole state.

106 million chronic painers and THIRTY national companies advertising/supporting this show/network… I would suspect that there is a lot of money exchanging hands for the products that they produce.. and those in the chronic pain community purchasing those produce. I am especially surprised that AARP is one of the sponsors of this program.. they claim that they represent 30 million 50+ people and I would suspect that at least 30%-40% of the people they claim that they represent… are chronic painers..  I wonder how many of their dues paying members are HEROIN ABUSERS ?

This story kind of reminds me of going into a “mirrored fun house”… what you see in the mirror doesn’t reflect REALITY…  Like all the pictures of models on magazine covers that are “Photo-shopped” to make them “look better”… in this case, FACTOIDS were “Photo-shopped” to make them look like the TRUTH  ?

a “focused” Squeaky wheel more often produces results

squeekywheel

Below is a story that was published on National Pain Report abt 10 days ago. I reached out to Cynthia because she seemed to be at her wits end. Mainly because of some hard-headed decision of her health insurer (United Health) not willing to pay for the only medication in a particular class – non -controlled med – that help her optimize her quality of life.  It wasn’t as if the medication was all that expensive abt $50/month. Abt the average price for a month supply of a generic. I reached out to Cynthia and made some suggestions to focus her complaints/appeal to get United Health and I just got a follow up email from Cynthia today… Cynthia – ONE…. United Health – ZERO

Dear Steve,

Delighted to report that on Tuesday United Healthcare approved my appeal! 🙂     
A big THANK YOU, sweet Steve, for your genuine care, concern and assistance in getting this denial reversed. I may have mentioned that I got an attorney on board. That, and working with my doctor’s assistant and you on the appeal did the trick.
I was deeply moved by the many wonderful people who reached out to help. That kindness overturned the arbitrary cruelty of my health insurance company. I just LOOOVE a happy ending. Thank you so much, Steve, for being a part of it ((*_*))
Wishing you a beautiful, stress-free day in Florida…Grace and Gratitude,Cynthia *:x lovestruck  

My Story: Healthcare Companies Causing Pain

www.nationalpainreport.com/my-story-healthcare-companies-causing-pain-8829665.html

By Cynthia Toussaint

Cynthia Toussaint

Cynthia Toussaint

My healthcare company, United Healthcare, is once again making me sick – and I’m mad as hell because I hate to be victimized. How can they arbitrarily take away a medication that’s been successfully working for decades!?

About 30 years ago, I started having severe pain in the left side of my abdomen and throat. This was on the heels of a ballet injury leaving me with excruciating right leg pain that had spread bi-laterally.  Nearly 14 years later I learned that I had Complex Regional Pain Syndrome.

While the leg pain made it impossible for me to dance – and for the most part walk – the abdomen and throat pain was more torturous because it left me unable to sing and even speak. I’m a talker and it was nothing short of hell to be doubled over with abdominal pain when I dared to let a sentence escape. In fact I ended up mute for five years using sign language and writing on a board to communicate with my life-partner and caregiver John.

I was eventually – after several endoscopies and different “crazy” labels – accurately diagnosed with a hiatal hernia which means my upper stomach was literally pushed out above my diaphragm. The pain was always at a level ten during those years as the accompanying acid reflux triggered a CRPS flare.

My GI doctor had me try three high-powered antacids, none of which controlled the reflux or pain and gave me extreme dizziness. He then patted me on the head, saying there was nothing more he could do and that I should stop thinking about it.

In desperation I sought out a young female doctor who was wonderfully caring. Dr. Gorman told me of a more expensive ant-acid medication that I should try. It was a miracle. The Axid immediately took away about 90% of the reflux and pain – and while limited from the CRPS flare, I was talkin’ up a storm again. Fifteen years later, I even began to sing.

Late last year I received a letter from my Medicare Part D provider informing me the generic version of the Axid I was taking (nizatidine) was no longer on their formulary.  I was further informed that I’d have to switch to one of the three generics I’d unsuccessfully tried 30 years prior.

I could either accept one of these offered meds and once again become doubled over in pain and mute – or fight along with my doctor to get a “formulary exception.” I chose to fight. And, boy, did we fight!

On December 22, it seemed victory was at hand when my doctor’s assistant informed me that her office had received an approval for nizatidine. But earlier this month when John went to pick up my script, he was told I was not covered by my insurance company. Yes, they had reversed their own decision without informing me – a practice my doctor’s assistant shared is not uncommon and drives everyone in their office batty!

Clearly we were (and are) battling a rigged system, a healthcare-for-profit scheme that has no concern for me or any patient. It was only about the bottom line. I was scared because I only had two weeks left of nizatidine…and talking.

Since then my doctor has worked thoroughly with me to file two URGENT appeals on my behalf. Both appeals were quickly denied. Worse yet, I got the news from an automated caller. They didn’t even have the decency to have a human being hand down my sentence. Perhaps that would be uncomfortable for them. Perhaps it would cost them money.

I have two days left of talking – and my doctor has put in one final “hail Mary” appeal. Please pray for me…

This is complete, utter madness. We need a law that prohibits health insurance companies from cutting patients off from meds that have given them quality of life and a reason to live for years, even decades. I intend to take up this battle with the legislators I know in Sacramento and DC… assuming I’m able to speak.

Cynthia Toussaint, who founded For Grace, a Los Angeles based non-profit that focuses attention on women in pain, writes occasionally for the National Pain Report.

Majority of IV Medication Errors Linked to Clinical Practice, Not Technology

Majority of IV Medication Errors Linked to Clinical Practice, Not Technology

http://www.infectioncontroltoday.com/news/2016/03/majority-of-iv-medication-errors-linked-to-clinical-practice-not-technology.aspx

Mistakes that occur during the administration of intravenous (IV) medications have long been one of the most common types of errors in hospitals, and for years many experts have believed that advances in technology—such as the use of so-called smart pumps—were the key to solving that problem. However, a new study suggests that eliminating administration errors is far more complex: Sound clinical practices and an adherence to those practices are crucial, as well as achieving true interoperability.

A new multihospital study published online in BMJ Quality & Safety calculated that more than half of infusions of IV medications contained errors—most of which had a low risk of patient harm—and the majority of these errors  were due to deviations in hospital policy.

Based on comparisons with previous studies, the researchers noted that medication-related errors were much lower, providing evidence that the implementation of smart pump technology has, in fact, improved infusion safety. However, the authors concluded that there was still “room for improvement” and that the next steps should focus on reviewing existing practices and policies pertaining to medication administration and achieving smart pump interoperability.

Smart pumps were developed to help reduce adverse drug events and medication administration errors through built-in safety features such as drug libraries and dose error reduction systems. According to a national survey conducted by the American Society of Health-System Pharmacists in 2012, 77 percent of hospitals in the United States use smart pump technology.

To provide insight into the type and frequency of errors that occur after hospitals have implemented smart pump technology, David Bates, MD, senior vice president and chief innovation officer at Brigham and Women’s Hospital in Boston, and a multidisciplinary team of researchers assessed 1,164 medication administrations conducted at 10 hospitals of varying sizes. All of these hospitals utilized smart pumps for infusions, although the pumps came from a variety of vendors.

During the study, 60 percent of infusions contained one or more errors. Violations of IV labeling and tubing change policies, which vary between hospitals, accounted for approximately 65 percent of the observed mistakes.

“Since these errors are not directly related to the use of smart pumps, these finding suggest that smart pump technology alone cannot fully prevent errors associated with intravenous infusions,” the researchers concluded. They went on to say that by characterizing these types of errors, they had identified opportunities to “streamline the intravenous medication administration process to avoid unintended consequences.”

Of the handful of potentially serious errors noted by the researchers, infusing medications at the wrong rate was observed most frequently, followed by administering unauthorized medications and omitting medications. Overall, just five of these errors were considered to possibly be able to cause temporary harm.

According to the researchers, none of the potentially harmful medication errors could have been prevented using current smart pump technology in the absence of interoperability. However, most of these mistakes could be prevented if “closed-loop interoperability between the smart pump and EHR was implemented,” the authors wrote.

In a closed-looped system, smart pumps can be automatically programed with a medication order using the patient’s EHR. Then the nurse must verify the information on the smart pump and accept the data—drug name, infusion rate, volume, and concentration—before the infusion can begin.

This study was funded by the AAMI Foundation from a grant provided by BD, formerly CareFusion, and is the result of a three-year collaboration. Bates presented the preliminary results of this research at last year’s kickoff meeting for the National Coalition for Infusion Therapy Safety.

“This research illustrates that while we have come a long way since our initial conversations about infusion safety at the 2010 AAMI/FDA Infusion Device Summit, there is still more work to do,” says Marilyn Neder Flack, senior vice president of patient safety initiatives at AAMI and executive director of the AAMI Foundation. “Researchers such as Dr. Bates are providing the clinical data that members of the AAMI Foundation’s National Coalition for Infusion Therapy Safety need to find evidence-based solutions.”

Virginia General Assembly passes medical marijuana production bill

Virginia General Assembly passes medical marijuana production bill

http://www.fairfaxtimes.com/articles/health_and_food/virginia-general-assembly-passes-medical-marijuana-production-bill/article_5efcbc40-e7c9-11e5-a75c-3fb151d110ab.html

This week, Virginia’s lawmakers passed a bill which will allow for the eventual production and distribution of low THC marijuana oils in the Commonwealth. After lengthy discussions and negotiations in both houses, SB701, Cannabidiol oil and THC-A oil; permitting of pharmaceutical processors to manufacture and provide, passed the House of Delegates unanimously on Monday. The bill returned to the Senate Tuesday with amendments and passed with a vote of 39-0. The bill now goes to the Governor’s desk for his signature.

“Providing this medication to Virginians is absolutely the right thing to do,” said Senator Dave Marsden, the sponsor of the legislation.“THCa and CBD oils have shown the ability to help alleviate the number and severity of seizures from intractable epilepsy and help so many families live a quality life. This is a huge step for Virginia, a first in the nation concept that will provide the medications in the safest most secure fashion and shows once again that Virginia leads the way.”

“I am pleased to have joined Senator Marsden once again in supporting legislation on this important issue. We must advocate for our most vulnerable Virginians. Passage of SB 701 is one of the many ways this can be done,” said Delegate Eileen Filler-Corn, co-sponsor of the legislation.

Last year’s passage of SB1235 andHB1445 gave intractable epilepsy patients and their caregivers an affirmative defense for possession of two marijuana oils, THCa and CBD used to treat seizures. However, the law provides no way for patients to obtain the oils without breaking federal and state laws. This legislation seeks to create a way to process and provide THCa and CBD Oils for patients with intractable epilepsy by requiring the Board of Pharmacy to create regulations to safely and securely provide the oils. Once the Board of Pharmacy creates the regulations they will be brought back before the legislature next year for final approval. Processing and distribution of the oils would not begin until sometime in 2017

“We are grateful to the Virginia General Assembly for allowing this first step towards helping epilepsy patients and their families obtain a safe and reliable treatment in the Commonwealth without breaking laws,” said Beth Collins, ASA director of communications and outreach. “The passage of SB701 will have a dramatic impact on the lives of patients by further expanding the medical cannabis program to allow access within the state of Virginia to low-THC extracts.”

Virginia is one of 40 states with medical marijuana laws and according to ASA’s latest report on Medical Cannabis Access in the U.S., is one of the seventeen states that limits use to CBD and THCa oils for certain conditions. Activists and legislators from across the country will be discussing these types of laws and other medical cannabis topics at Americans for Safe Access’s 4th Annual Medical Cannabis Unity Conference in Washington, DC later this month.

drug dealer claims that legalizing Heroin will put him out of a job

New York Becomes First State to Legalize Heroin

www.diseasestreatment.info/new-york-becomes-first-state-to-legalize-heroin/

The state of New York made history this week, following on the heels of the wave of marijuana legalizations across the country. Recreational use of heroin will become fully legal in the state by the end of this year.

The decision was met with controversy, but “no more or less than the original decision to legalize marijuana,” Governor Andrew Cuomo stated. The state is still figuring out some guidelines and ground rules for suppliers, such as purity levels, permits, and health code requirements.

One of the major points in making this decision came from the number of dealers and users of the drug who repeatedly end up in New York’s correctional facilities.

 

“By legalizing, monitoring, and taxing heroin, we will not only cut down on inmates and care costs, but also open up a whole new job market,” Cuomo explained. “It’s a good situation all around, especially for taxpayers.”

A program is already in its early stages to rehabilitate and compensate imprisoned heroin dealers to return to society and act as the leading distributors, hoping to speed up this process while simultaneously reintroducing inmates to society.

Some of the decision’s most outspoken opponents, however, have been current dealers.

“Making it legal is a terrible idea,” a dealer, who chooses to remain anonymous, told us. “We don’t want it regulated. We make good money how it is now, but regular guys like me won’t be able to keep up with all the government regulations. This is gonna put me out of a job!”

 Nonetheless, experts estimate this act will drop the state’s debt by as much as 50% in the first year. This may translate into tax cuts, more public projects, better road maintenance, and possibly even government rehabilitation programs for more dangerous drugs like cigarettes.

Doc linked to 3 pt’s deaths… but no controlled meds involved… so no charges ?

Doctor given prison for taking kickbacks to prescribe risky drug

http://www.chicagotribune.com/news/local/breaking/ct-medicare-fraud-kickbacks-sentencing-met-20160311-story.html
Get the stories that make Chicago. All of the time. On every device. Try Unlimited Digital Access for 99¢.
News Local news Breaking News
Doctor given prison for taking kickbacks to prescribe risky drug
Reinstein sentenced

Dr. Michael Reinstein, right, leaves the Dirksen U.S. Courthouse on March 11, 2016, after being sentenced to nine months in prison for accepting almost $600,000 in kickbacks to prescribe a risky antipsychotic drug to thousands of patients in Chicago nursing homes and mental health clinics. (Phil Velasquez / Chicago Tribune)
Jason MeisnerContact ReporterChicago Tribune

A Chicago doctor who was once the nation’s most prolific prescriber of the risky antipsychotic drug clozapine was sentenced to nine months in prison Friday for taking cash, vacation trips and other kickbacks from the drug’s manufacturers.

Dr. Michael Reinstein, the subject of a 2009 Tribune-ProPublica joint investigation, admitted to pocketing nearly $600,000 in benefits over the years for prescribing various forms of clozapine, known as a risky drug of last resort, to hundreds of mentally ill patients in his care.

In rejecting calls by defense lawyers for probation, U.S. District Judge Sharon Johnson Coleman noted that like so many other doctors convicted of fraud schemes, Reinstein served a largely underprivileged group of people who are unable to fend for themselves.

The judge also said that regardless of whether he thought the drug was helping his patients, Reinstein violated the sacred doctor-patient trust by accepting the cash.

Promoted stories from PoliticsChatter.com
Obama and Trudeau: Dancing and bromancing
Chicago hot dog joint rolls out 3-inch ‘Trump Footlong’
Here’s where the Democratic party delegate count stands

“That is the biggest danger here,” Coleman said. “It leaves a cloud over the patients and their families over whether they were put at some unnecessary risk. All of those questions are in their heads. … When money is inserted into the equation, there is no trust.”
Doctor admits taking kickbacks for prescribing risky drug
Doctor admits taking kickbacks for prescribing risky drug

When he pleaded guilty last year, Reinstein also settled a massive civil lawsuit brought by the U.S. attorney’s office alleging that he submitted more than 140,000 false Medicare and Medicaid claims as part of the kickback scheme. He was ordered to pay more than $3.7 million in penalties to the U.S. government and the state of Illinois.

In addition to the prison time, Coleman ordered Reinstein to forfeit an additional $592,000 and serve 120 hours of community service when he’s released from custody.

Reinstein, 72, of Skokie, showed no reaction to the sentence. Moments earlier, he had stood in the courtroom and apologized for his crime and the embarrassment it caused his family members, many of whom choked back tears in the courtroom gallery.

But as he had in the past, Reinstein defended his use of clozapine, which he said has been unfairly portrayed by prosecutors as dangerous.

“I’ve been working with this medicine since 1971,” said Reinstein, whose medical license was indefinitely suspended by state regulators in 2014. “It has helped many, many, many patients who were not helped by other drugs.”
Feds charge suspended doctor in clozapine kickback case
Feds charge suspended doctor in clozapine kickback case

First licensed in Illinois in 1968, Reinstein built a lucrative practice providing psychiatric care to mentally ill patients in nursing homes concentrated near his strip mall office in the city’s Uptown neighborhood.

The Tribune-ProPublica investigation found that Reinstein had amassed a worrisome record of assembly line care that was linked to three patients’ deaths and triggered lawsuits as well as accusations of fraud. But the federal charges did not include any accusations of patient deaths.

In his plea agreement, Reinstein admitted that, beginning in the 1990s, he prescribed the brand-name version of clozapine to hundreds of his patients while receiving $234,000 from the manufacturer. Reinstein admitted that the payments, ostensibly for speaking engagements touting the drug, were in part for prescribing the drug to so many patients.

When Ivax Pharmaceuticals began making a generic form of clozapine in 2003, Reinstein struck a $50,000-a-year consulting agreement with the company, quickly becoming among its largest prescribers in the country.

Over the next three years, Ivax provided other perks to Reinstein and his associates, including expensive meals, tickets to sporting events and an all-expense-paid trip to Ivax’s headquarters in Miami, where Reinstein went on fishing trips, a cruise and a golf outing, according to prosecutors.

Reinstein faced up to three years in prison but was given a break in his recommended sentence because he cooperated with prosecutors on several other health care fraud investigations, including secretly recording conversations with other doctors, court records show. It was not disclosed whether any of those investigations led to criminal charges.

In asking Coleman for a sentence of a year and half in prison, Assistant U.S. Attorney Eric Pruitt said only 4 or 5 percent of all the patients nationwide who are on antipsychotic drugs are taking clozapine. Meanwhile, the “vast majority” of Reinstein’s patients were on the medication, Pruitt said.

“It is a staggering difference,” Pruitt said.

jmeisner@tribpub.com

Twitter @jmetr22b